Living meta-analysis and evidence synthesis of therapies for COVID-19

 

• COVID 19 hospitalized
• COVID 19 all comers
• COVID-19 mild to moderate
• COVID-19 severe or critically
• COVID 19 outpatients
• COVID-19 (hospitalized or not)
• COVID-19 prophylaxis (children)
• COVID-19 prophylaxis (excluding children)
• infections other than COVID-19
• Long COVID-19
• preventing respiratory virus transmission
• secondary prevention

 

• adjuvant therapies
• face mask
• anti-inflammatoty and immuno-therapy
• anti-inflammatory therapies
• Immunostimulants drugs
• convalescent plasma treatment
• antiviral and associated therapy
• azithromycin
• chloroquine and derivatives
• oseltamivir
• vaccines
• ebola vaccine
• Non replicating viral vector
• Ad26.RSV.preF (respiratory syncytial virus)
• Ad26.ZEBOV ()
• Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine)
• All treatment (not recommended)

    Top evidence (RCT only, high risk of bias excluded) Best available evidence (possibly low or very low) All RCTs All studies (RCT+OBS) see more...